Search Results
Jun 01, 2026, 08:00 ET Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development
track designation. Prior to Full-Life, he was CMO of Pega-One, a clinical-stage oncology company that became part of Centessa Pharmaceuticals (Nasdaq: CNTA) ahead of its $380 million initial public offering. Earlier, he served as CMO of NBE-Therapeutics, where he led the IND submission and initial clinical
More news about: Actinium Pharmaceuticals, Inc.
May 19, 2026, 18:24 ET Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-sem-unf-cnta-asrt-obtaining-fair-deals-for-their-shareholders-302776865.htmlSOURCE
More news about: Halper Sadeh LLP
May 12, 2026, 02:49 ET Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-cnta-wsr-gdot-obtaining-fair-deals-for-their-shareholders-302768946.htmlSOURCE
More news about: Halper Sadeh LLP
May 11, 2026, 15:12 ET $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA
CNTA) related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, Centessa shareholders are expected to receive $38.00
More news about: Monteverde & Associates PC
Apr 20, 2026, 16:33 ET Are CNTA, KORE, CWAN Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-cnta-kore-cwan-obtaining-fair-deals-for-their-shareholders-302747599.htmlSOURCE
More news about: Halper Sadeh LLP
Apr 10, 2026, 13:34 ET Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-apls-cnta-kzr-obtaining-fair-deals-for-their-shareholders-302739362.htmlSOURCE
More news about: Halper Sadeh LLP
Apr 08, 2026, 14:15 ET SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS
CNTA) related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, Centessa shareholders are expected to receive $38.00
More news about: Monteverde & Associates PC
Apr 07, 2026, 14:48 ET Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-apls-kore-cnta-obtaining-fair-deals-for-their-shareholders-302736032.htmlSOURCE
More news about: Halper Sadeh LLP
Apr 01, 2026, 16:14 ET SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Centessa Pharmaceuticals plc (NASDAQ: CNTA)
CNTA) related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, Centessa shareholders are expected to receive $38.00
More news about: Monteverde & Associates PC
Mar 31, 2026, 12:00 ET Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders
MILWAUKEE, March 31, 2026 /PRNewswire/ -- LLP is investigating Centessa (NASDAQ: CNTA) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Lilly.
More news about: Ademi LLP
Mar 31, 2026, 11:38 ET Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-apls-cnta-bird-obtaining-fair-deals-for-their-shareholders-302730253.htmlSOURCE
More news about: Halper Sadeh LLP
Mar 31, 2026, 06:45 ET Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
LONDON, March 31, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, today
More news about: Eli Lilly and Company